Using Machine Learning to Support Early Palliative Care Involvement in Pediatric Cardiology Patients
Led by The Hospital for Sick Children · Updated on 2026-04-23
1000
Participants Needed
1
Research Sites
15 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness of a machine-learning ML model in predicting serious cardiac events within three months among pediatric cardiac inpatients. The study focuses on determining whether the ML model increases palliative care team PACT consultations, reduces time to consultation, decreases ICU deaths, and improves documentation of care goals. The study is conducted at The Hospital for Sick Children, leveraging their strong collaboration between cardiology and palliative care.
The ML model identifies high-risk cardiology patients daily. If a patient was seen by PACT in the past year, the update goes to the PACT team otherwise, the cardiology physician in charge receives the alert to decide on consultation. The study compares patient outcomes before and after deploying the ML model, with a pre-deployment period covering 12 months starting 15 months before deployment, and a post-deployment period covering 12 months beginning 3 months after deployment.
Participants are pediatric cardiology inpatients. Researchers will monitor PACT consultations within three months of admission, time to consultation, ICU death rates, and documentation of care goals. Outcomes among identified high-risk patients will be compared between the pre- and post-deployment periods to assess the ML models impact on care processes and patient outcomes.
CONDITIONS
Brief Title
PACT Involvement in Cardiology Patients
Research Team
L
Lillian Sung, MD, PhD
A
Agata Wolochacz, BMSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Expected to be discharged prior to midnight on the day of admission
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
ML-based Intervention
Duration - Up to 3 months following enrolment
Participants identified by a machine learning model as having the highest risk of serious cardiac outcomes receive earlier involvement from the palliative care team.
Participants may have palliative care consultations or visits as indicated within 3 months
Follow-up
Duration - Up to 3 months following intervention
Participants are monitored for outcomes including palliative care involvement and clinical events for up to 3 months after enrolment.
Ongoing monitoring with no required visits beyond standard care
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Using Multi-modal Ultrasound and Deep Learning to Estimate Blood Volume Before Surgery in Adults Aged 18 to 75
Predicting Treatment Results of Brain Stimulation and Cognitive Training in Adolescents with Autism Spectrum Disorder Using Machine Learning
Study of Hospital Care in Managing Emergencies for Children Under Pediatric Palliative Care
Using a Machine Learning Tool for Blood Culture Decisions in Adults Visiting the Emergency Department A Randomized Trial
Using Artificial Intelligence to Automatically Extract and Process Clinical Data from Electronic Medical Records in Cardiology Patients
Machine Learning Prediction Model for Early Mobility Recovery and Hospital Stay After Hip or Knee Replacement Surgery
Study to Develop and Validate a Digital Tool to Detect Normal and Abnormal Heart Sounds in Newborns Under 30 Days Old
Home Sleep Therapy Using Non-Invasive Brain Stimulation to Improve Deep Sleep and Memory in Older Adults with Mild Cognitive Impairment
Study of Lean Pork and Plant-Based Diets on Heart and Menopause Symptoms in Overweight Perimenopausal Women Ages 40 to 55
Using Machine Learning to Predict How Long Spinal Anesthesia Lasts
in Total Knee Replacement Surgery
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update.